SRSF2 and neoplasm: To more directly assess whether increased SRSF2 has a role in increased tumor initiation capacity, we selected one of the stable knockdown cell lines (SRSF2 sh2) to test whether downregulating SRSF2 yields decreased tumor initiation capacity in the high tumorigenic context of MDA‐MB‐468 cells in DIO mice.